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Summary
 
Accumulating evidence shows that the repertoire of major histocompatibility complex class
I–restricted epitopes extends beyond conventional translation reading frames. Previously, we
reported that scanthrough translation, where the initiating AUG of a primary open reading
frame is bypassed, is most likely to account for the presentation of cryptic epitopes from alter-
native reading frames within the influenza A PR/8/34 nucleoprotein gene. Here, we confirm
and extend these findings using an epitope cassette construct that features two well-defined
CD8
 
1
 
 T cell (T
 
CD8
 
1
 
) epitopes in alternative reading frames, each preceded by a single start
codon. Expression of one epitope depends on scanning of the ribosome over the first AUG
with translation initiation occurring at the second AUG. We find that scanthrough translation
has great potency in our system, with its impact being modulated, as predicted, by the base
composition surrounding the first initiation codon, the number of start codons preceding the
point of alternate reading frame initiation, and the efficiency with which the epitope itself is
generated. Additionally, we investigated the efficiency of eukaryotic translation termination
codons, to assess codon readthrough as a mechanism for cryptic epitope expression from 3
 
9
 
 un-
translated regions. In contrast with initiation codons, eukaryotic stop codons appear to be
highly efficient at preventing expression of epitopes encoded in 3
 
9
 
 untranslated regions, sug-
gesting that 3
 
9
 
 untranslated regions are not a common source of cryptic epitope substrate. We
conclude that scanthrough is a powerful mechanism for the expression of epitopes encoded in
upstream alternative open reading frames that may contribute significantly to T
 
CD8
 
1
 
 responses
and to tolerance induction.
 
T
 
CD8
 
1
 
 activation depends upon interaction between the
clonotypic TCR and a MHC class I molecule com-
plexed with an 8–10 amino acid peptide epitope (1–5).
Conventional models of antigen processing and presenta-
tion generally presume these epitopes to be derived from
the cytosolic proteolysis of full-length, fully translated proteins.
However, it has been demonstrated that T
 
CD8
 
1
 
 are also capable
of recognizing either the products of gene fragments or mini
genes expressing the minimal sequence of an epitope (6–8).
In addition, there is sufficient evidence in the literature to sug-
gest that strict adherence to conventional translation is not
required for antigen presentation. Examples include the pre-
sentation of epitopes encoded in untranslated regions (UTRs)
 
1
 
(9, 10) and in alternative reading frames (RF) (11–15). This
implies that regions of genes that are traditionally thought
to be inaccessible to translation could be a potentially sig-
nificant source of substrate for antigen processing and pre-
sentation.
The generally accepted model for translation initiation of
most messages is the ribosomal scanning hypothesis (16–
18), where a ribosome scans from the 5
 
9
 
-cap and begins
translation from the first AUG in favorable context, as de-
termined by surrounding nucleotide identity. This AUG
defines the primary RF, or RF0. Extensive surveys of eu-
karyotic genes have shown that in most cases the first AUG
encountered is in favorable context (19, 20) and biochemi-
cal studies have shown that a primary start codon is used by
the great majority of scanning ribosomes (21). However,
some ribosomes fail to initiate at the primary initiation
codon, with factors such as proximity to the 5
 
9
 
-cap, and lo-
 
1
 
Abbreviations used in this paper: 
 
NP, nucleoprotein; nt, nucleotide; ORF,
open reading frame; RF, reading frame; T
 
CD8
 
1
 
, CD8
 
1
 
 T cell; UTR, un-
translated region; vac, vaccinia virus.
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cal secondary structures as well as initiation codon context
having influence (22, 23). We have recently demonstrated
that initiation codon readthrough (scanthrough) is probably
responsible for the production of epitopes encoded in alter-
native RFs from a mutated influenza A PR/8/34 nucle-
oprotein (NP) gene (24). In the system studied, it appeared
that scanthrough was capable of utilizing an internal AUG
codon to rescue the presentation of three NP epitopes
(NP
 
50–57
 
, NP
 
147–155
 
, NP
 
366–374
 
) that had been shifted out-of-
frame by a base deletion in the second codon of the NP
open reading frame (ORF). In addition to providing this
alternative source of out-of-frame epitopes, scanthrough
translation may simultaneously produce truncated, in-frame
polypeptides that could be more efficiently processed than
full-length protein by the class I processing machinery.
This mechanism could also provide a plausible rationale for
the presentation of exocytic proteins that do not normally
access the cytosolic protein-degradation apparatus, by al-
lowing initiation of translation after the signal sequence en-
coding region, resulting in the production of a nontranslo-
cated substrate.
As in the case of start codons, not all translation stop
codons cause termination of translation with equal effi-
ciency. The sequence surrounding the termination codon
dictates whether some readthrough and continued transla-
tion can occur. In 
 
Saccharomyces cerevisiae
 
, termination
codon readthrough has been shown to occur at levels up to
3.35% (25). This mechanism would allow for translation
from the 3
 
9
 
 UTR, further expanding the available substrate
for class I presentation.
In the current study, we have constructed a presentation
cassette in order to assess the potential for ribosomal scan-
through in epitope expression under controlled conditions.
This allowed us, first, to confirm our previous findings
concerning initiation codon readthrough and, second, to
assess directly the strength of initiation codon readthrough
in the face of competitive AUG codons encoded in alter-
nate RFs. In addition, we wished to discern whether
epitopes encoded in 3
 
9
 
 UTR are also available for presenta-
tion. For this purpose, we tested the ability of ribosomes to
read through strong and weak RF0 stop signals inserted in
wild-type NP and translate a downstream epitope. These
studies provide important insights into the translation
mechanisms available for the production of substrate from
unconventional coding regions.
 
Materials and Methods
 
Chemicals
 
General chemical supplies were obtained from Sigma (St.
Louis, MO). Molecular biology reagents were obtained from
New England Biolabs (Beverly, MA), except where noted.
 
Animals
 
6 to 8-wk-old female inbred CBA (H-2
 
k
 
), BALB/c (H-2
 
d
 
),
and C57BL/6 (H-2
 
b
 
) strain mice were obtained from Taconic
(Albany, NY) or Jackson Labs (Bar Harbor, ME) and maintained
in Kimmel Cancer Center Animal Facilities (Philadelphia, PA).
 
Tissue Culture
 
L929 (H-2
 
k
 
), L-Kd (H-2
 
k
 
, H-2K
 
d
 
; L929 transfected with
H-2K
 
d
 
; reference 26) and MC57G (H-2
 
b
 
) cells were maintained
under standard conditions. Specifically, they were grown in
DMEM supplemented with 5% FCS (Sigma) and incubated at
37
 
8
 
C and 9% CO
 
2
 
.
 
Molecular Manipulations
 
All enzymes used for the manipulation of the NP gene were
used according to the instructions of the manufacturer. PCR
primers and oligonucleotide linkers were synthesized by the Kimmel
Cancer Institute Nucleic Acid Facility (Philadelphia, PA). NP
containing a silent Apa I site in the H-2K
 
d
 
 (bp 457–463) epitope
has been described elsewhere (8). Silent PCR directed mutagene-
sis was used to incorporate an Aat II site in the H-2K
 
k
 
 epitope (bp
165–171): GAG GGA CGT CTG ATC. These altered sites were
then used in additional cloning of the NP gene. Most manipula-
tions were done using a Bluescript II SK(
 
1
 
) vector (Stratagene,
La Jolla, CA) with NP inserted in the EcoRI site of the MCS.
 
Variable Initiation Cassettes.
 
The region between the NP
 
50–57
 
and NP
 
147–155
 
 epitopes was removed by AatII to ApaI digestion of
the NP gene in Bluescript II SK (
 
1
 
). The resulting vector was
then ligated (T4 ligase; GIBCO BRL, Gaithersburg, MD) with
an oligo pair encoding the reconstituted epitopes separated by 5
nucleotides (nt) and the initiation cassette consisting of an excel-
lent context for ATG
 
RF0
 
 and an excellent context for ATG
 
RF
 
1
 
1
 
.
The two ATG codons were in alternate reading frames and sepa-
rated by 13 nt, partially encoding a KpnI site for later manipula-
tions. Oligonucleotide sequences (upper oligo only), TCG ACG
GAT TAT GGC GGT ACC GGA TTA TGG CAA GCG ATT
ACG AGG GAC GT and CTG ATC ACG CGA CTT ATC
AGA GGA CAA GGG CC. After construction of the excellent–
excellent cassette, we altered the context of the ATG
 
147–155
 
 initia-
tion codon using synthetic oligonucleotides. The initial construct
was digested with SalI and KpnI to excise the ATG
 
RF0
 
 initiation
region. Oligos encoding a similar initiation codon with different
surrounding context were ligated into this site. Good context,
TCG ACG GAT TAT GTC CGT AC. Fair context, TCG ACG
GGT TAT GTC CGT AC. Poor context, TCG ACG GTT
TAT GTC CGT AC. Null context, TCG ACG GAT TTT
TGC CGT AC. The null construct for the downstream RF
 
1
 
1
was generated by KpnI to ApaI digestion of the excellent context
of RF0 construct and replacement with an oligonucleotide pair
designed to ablate the KpnI site and mutate the RF
 
1
 
1 start
codon from AUG to ATC. The upper strand of the pair reads
GGG ATT ATC GCA AGC GAT TAC GAG GGA CGT (un-
derline indicates the mutations). All the cassette variants were se-
quenced and then transferred to pSC11 via a SalI–NotI fragment
containing the manipulated gene.
The reverse-frame cassette was made by digesting the excellent
context of RF0 construct with KpnI and ApaI and replacing that
fragment with a synthetic oligo pair that retained the KpnI site,
inserted a single base (C) right after the KpnI site and a base (G)
immediately following the ATG. The upper strand reads CCG
GAT TAT GGG CAA GCG ATT ACG AGG GAC GT (in-
serted bases are indicated by underline). The null context of RF0
was created as described above for the variable initiation cassettes.
 
Variable Context Stop Codons.
 
The NP gene in pSC11 was
digested with BstBI and treated with alkaline phosphatase. Into 
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the BstBI site, self-annealing oligos encoding either a strong
(CGT ATA AGC GCG CTT ATA) or weak (CGT ATG ACC
GCG GTC ATA) stop signals were ligated. Correct ligations
were analyzed by the loss of the BstBI site.
 
Viruses
 
Control vaccinia virus (vac), NP-expressing vaccinia virus, and
the NP
 
D51T
 
 mutant designed to ablate the NP
 
50–57
 
 epitope have
been described elsewhere (24). Other recombinants described
here were made as previously described (8). In brief, all altered
genes were ligated between the SalI and NotI sites in modified
pSC11 for expression from the P
 
7.5
 
 promoter. These plasmids
were then introduced into the vaccinia genome via homologous
recombination in CV-1 cells (American Type Culture Collection
[ATCC], Rockville, MD; CCL 70) and plaque purified in 143B
HuTK
 
2
 
 (ATCC; CRL 8303) cells in the presence of BrdU (Boeh-
ringer Mannheim, Indianapolis, IN). In all cases, the integrity of
the recombinant was determined by isolating vac DNA and se-
quencing after PCR amplification of the mutant gene.
 
CTL Assay
 
APC were infected for 1 h at 37
 
8
 
C with vac recombinants at
10 PFU/cell at a concentration of 10
 
7
 
 cells/ml in balanced salt so-
lution containing 0.1% BSA. After 1 h, 10 ml of preconditioned
(37
 
8
 
C, 9% CO
 
2
 
) DMEM 
 
1
 
 5% FCS were added and the cells in-
cubated a further 3 h with rotation. Cells were pelleted and resus-
pended with 50 
 
m
 
l/10
 
6
 
 cells of IMDM with 7.5% FCS containing
100 mCi of Na
 
51
 
CrO
 
4
 
 (Amersham Corp., Arlington Heights, IL)
and incubated for 1 h at 37
 
8
 
C. APC were then washed three
times with DPBS and resuspended in IMDM and combined with
CTL populations in round bottomed plates at 10
 
4
 
 cells/well.
APCs and CTL were coincubated for 4 h at 37
 
8
 
C before 100 
 
m
 
l
of supernatants were collected and counted in a 
 
g
 
 detector (Phar-
macia, Sweden). The data are presented as percent specific 
 
51
 
Cr
release, defined as 100 
 
3
 
 ([experimental cpm 
 
2 
 
spontaneous
cpm] / [total cpm 
 
2
 
 spontaneous cpm]).
 
Generation of CTL
 
T
 
CD8
 
1
 
 restricted to H-2
 
k
 
, H-2
 
d
 
, or H-2
 
b
 
 were derived from
NP-immunized CBA, BALB/c, or C57BL/6 mice, respectively,
as described elsewhere (27). Mice were immunized by intraperi-
toneal injection of 10
 
7
 
 PFU of NP–vac in the case of C57BL/6, a
vac expressing the isolated NP
 
50–57
 
 epitope in the case of CBA,
and a vac expressing the isolated NP
 
147–155
 
 epitope in the case of
BALB/c. After at least 2 wk, spleens from appropriate mice were
harvested and one-third of cells infected with PR8 for restimula-
tion. Secondary cultures were incubated at 37
 
8
 
C, 9% CO
 
2
 
 for
6–7 d before harvesting for effector populations.
 
Results and Discussion
 
Confirmation of Initiation Codon Scanthrough as a Viable
Mechanism for MHC Class I Epitope Production.
 
Our analy-
sis of a series of frameshift mutations of the NP gene led us
to suggest that ribosomal scanthrough of an initiation
codon can provide a significant amount of substrate for
epitope production from unconventional coding regions
(24). A recombinant vac encoding the NP gene with a de-
letion in the second codon was able to express three NP
epitopes, NP
 
50–57
 
 (H-2K
 
k
 
-restricted), NP
 
147–155
 
 (H-2K
 
d
 
-
restricted), and NP
 
366–374
 
 (H-2D
 
b
 
-restricted), as assessed by
sensitization of target cells in vitro. This mutant was also
able to prime mice for anti-NP
 
366–374
 
 responses at levels
similar to those achieved by priming with wild-type NP-
expressing vac. We were able to identify an internal AUG
codon that played a prominent role in overcoming the
frameshift and permitting the expression of the three NP
epitopes. Owing to the location of the initiation and termi-
nation codons involved, scanthrough was determined to be
the most likely mechanism operating in the expression of
these epitopes.
We wished to confirm the potential of scanthrough in a
controlled system that is not subject to alternative transla-
tion mechanisms such as reinitiation, in which the ribo-
some terminates translation and starts again at a downstream
AUG (28–30). Kozak (23) has shown, using standard bio-
chemical techniques, that the degree of scanthrough is de-
pendent upon the context surrounding the first AUG (defined
by the following optimal sequence: CC(
 
A
 
/
 
G
 
)
 
2
 
3
 
CCAUGG
 
1
 
4
 
,
in which the 
 
2
 
3 purine and the 
 
1
 
4 guanine are most im-
portant) and that scanthrough initiation is limited to the
upstream region of the message (31). We created a trun-
cated NP gene in which the region between the NP
 
50–57
 
and NP
 
147–155
 
 epitopes was eliminated, leaving them sepa-
rated by 5 nt (Fig. 1 
 
a
 
). This had the effect of putting the
two epitopes in alternate RFs: NP
 
50–57
 
 in RF
 
1
 
1, NP
 
147–155
 
in RF0, with no alternative RF stop codons that could in-
fluence the expression of these epitopes. Mutation of the
residues required for binding to the MHC class I molecule
has confirmed that H-2
 
k
 
 and H-2
 
d
 
 responses are limited to
NP
 
50–57
 
 and NP
 
147–155
 
, respectively (24). In front of the two
epitopes we placed a translation initiation cassette consist-
ing of tandem start codons in the same reading frames as
the two epitopes. The second ATG (RF
 
1
 
1, excellent con-
text) is in frame with NP
 
50–57
 
. This start codon is preceded
by an ATG in RF0 with varying contexts that are pre-
dicted to influence significantly the efficiency of translation
initiation. Based upon established results (32), four contexts
were provided that we designated excellent (A at 
 
2
 
3, G at
 
1
 
4), good (A at 23, T at 14), fair (G at 23, T at 14), and
poor (T at 23, T at 14). In this range, the level of initia-
tion is predicted to vary over 10-fold. The AUGRF0 is in
the same frame as the NP147–155 epitope. To confirm that
the epitopes depend upon the RF0 and RF11 AUGs for
expression we mutated either the RF0 or RF11 ATG
while keeping the remaining ATG in excellent context. A
predicted outcome for the translation of this cassette is that
a scanning ribosome should first encounter the AUGRF0,
responsible for translation of NP147–155. However, a per-
centage of scanning ribosomes will bypass it, with some
level of initiation occurring at the second AUG, resulting
in the expression of NP50–57. We anticipated that, as the
initiation context surrounding AUG147–155 was improved,
more ribosome would be competed away from translating
in the RF11 and directed into RF0, resulting in decreased
presentation of NP50–57.
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nome to assay for the expression of these two epitopes by
infected target cells in a standard 51Cr release assay. To
measure presentation of both epitopes in the same target
cell, we utilized L929 (H-2k) cells transfected with the gene
encoding the Kd class I molecule (26). Presentation of the
NP147–155 epitope was quite strong when driven by initia-
tion codons in either good or excellent contexts (Fig. 1 b).
Levels of specific lysis were comparable to those associated
with infection by a wild-type NP-expressing vac. Of note,
presentation was diminished when the RF0 ATG was
placed into fair and poor contexts. Mutation of the RF0
ATG resulted in complete loss of lysis above control levels,
confirming its essential role in expression of the NP147–155
epitope.
It is generally understood that TCD81 are exquisitely sen-
sitive, requiring very little antigen expression and very few
peptide–class I complexes at the cell surface to trigger effec-
tor function (13, 33–35). In this light, the diminution of
NP147–155 presentation resulting from downgrading of the
RF0 ATG may be unexpected. However, we and others
have noted the relative inefficiency with which NP147–155 is
presented (24, 36, 37), probably because of a major site for
proteasome attack within the epitope (36). Antón et al. (37)
have estimated that only 30 NP147–155–Kd complexes result
from the processing of wild-type NP. This compares with
1,800 NP50–57–Kk complexes. Further supporting the no-
tion that NP147–155 expression is close to, if not below, lev-
els associated with maximal T cell stimulation, we have re-
cently noted that a 2- to 5 fold reduction in wild-type NP
expression within target cells is sufficient to reduce NP147–155-
specific lysis appreciably (Yellen-Shaw, A.J., K.A. Puorro,
and L.C. Eisenlohr, unpublished data). Using proinsulin
synthesis as a readout, Kozak observed that a change from
excellent to good context results in an z2-fold decrease in
expression, from good to fair, a 3.7-fold decrease, and from
fair to poor, a decrease of at least 3.5-fold (32). Together,
this information provides an explanation for the lower pre-
sentation of NP147–155 in the fair and poor contexts.
Presentation of the NP50–57 epitope, which depends
upon bypass of the RF0 AUG by a sufficient portion of ri-
bosomes, followed a pattern predicted by the scanning hy-
pothesis. When the RF0 AUG is in poor, fair, and good
contexts, specific lysis was not significantly different from
that associated with the ATG147–155 null construct. When
the RF0 ATG is in excellent context, presentation of NP50–57
was clearly compromised, though consistently present. This
is reinforced by data from a separate assay shown in Fig. 2,
which provides specific lysis figures over several effector/
target ratios. The importance of the RF11 AUG for this
expression is confirmed by the low lysis associated with the
Figure 1. Presentation of an epitope in a downstream alternative read-
ing frame depends upon the context and number of upstream initiation
codons in the primary reading frame. (a) MHC class I presentation cas-
sette. Two MHC class I–restricted epitopes, NP50–57 and NP147–155, were
placed in alternate RFs, each translated by different AUG initiation
codons. The first AUG encountered by the scanning ribosome is in vari-
able context and initiates translation of NP147–155. The second AUG is in
excellent context and initiates translation of NP50–57. After NP147–155, the
sequence of NP is unaltered. Start codons or their null equivalents are in-
dicated in bold. The 23 and 14 nucleotides involved in changing the
initiation potential are underlined. (b) Scanthrough is an efficient mecha-
nism of translation from alternative RFs. The MHC class I presentation
cassette variants were recombined into the vac genome and tested for sen-
sitization of L-Kd cells for lysis in a standard 51Cr release assay. Specificity
of the TCD81 effector population, generated as described in Materials and
Methods, is indicated above each data set. The effector/target ratios
shown are 30:1 for recognition of NP147–155 and 13:1 for NP50–57, respec-
tively. Similar results were observed with three other ratios.
Figure 2. Presentation of NP50–57 from selected constructs. The indi-
cated constructs were tested for target cell sensitization in a standard 51Cr
release assay.1055 Bullock et al.
AUGRF11 null construct. In this assay, levels were above
those associated with control virus, but in other assays (see
Fig. 2) the two were comparable. We also note the com-
plete loss of NP50–57-specific lysis with a single mutation
within the NP50–57 epitope. In our previous publication,
we observed only partial loss of lysis with this mutant (24).
As we used NP50–57-expressing vac to prime mice for effec-
tor populations in the studies reported here, and full-length
NP vac for this purpose in the previous work, we strongly
suspect the existence of a weaker H-2k–restricted epitope
within NP. Such an epitope has been suggested by Daly et
al. (38) who generated a Kk-restricted T cell hybridoma
with reactivity to NP that does not map to NP50–57.
In accord with the scanning hypothesis, we reasoned that
multiplying the number of RF0 start codons in excellent
context would track a higher proportion of ribosomes to
RF0, further reducing presentation of NP50–57. Therefore,
the single start codon module was replaced by a string of
triple RF0 start codons, each in excellent context. This
strategy significantly reduced levels of NP50–57 presentation.
This construct is also shown in Fig. 2, where no lysis above
that associated with negative control virus was observed.
These results demonstrate that even when the preceding
start codon is in excellent context, there is a degree of
scanthrough that permits presentation of an epitope in an
alternative reading frame. As the context surrounding the
primary AUG becomes more favorable, the potential for
epitope expression in the alternative reading frame de-
creases. Epitope expression in the alternative reading frame
was clearly compromised when the RF0 AUG was in ex-
cellent context. An extensive survey of vertebrate mRNAs
revealed that only 25% have primary start codons in excel-
lent context. Good and fair contexts are each present in
36% (72% total) of messages (20). Thus, the majority of
messages are predicted to feature a level of scanthrough that
would permit strong expression of an epitope in an alterna-
tive reading frame. The results further demonstrate that the
level of scanthrough is also influenced by the number of
upstream start codons in alternative RFs.
Reversal of the Cassette. As discussed above, the NP147–155
epitope is inefficiently generated compared with NP50–57.
Therefore, conditions that permit activation of NP147–155-
specific TCD81 via scanthrough may be more limited. To
test this, the pairing of the first and second start codons with
NP147–155 and NP50–57 was reversed as depicted in Fig. 3 a
and described in Materials and Methods. This placed the
first AUG and NP50–57 in RF0 and the second AUG and
NP147–155 (as well as the rest of NP, residues 156–498) in
RF-1. Whereas NP50–57 in an alternative RF could be pre-
sented in the face of an upstream RF0 AUG in excellent
context (see Fig. 2 b; Fig. 3), presentation of NP147–155 in
the same circumstance could not be detected (Fig. 3 b).
Thus, in addition to the context and number of upstream
AUGs, the epitope itself can determine the potential for
TCD81 activation via scanthrough.
Altogether, our data indicate that scanthrough and read-
ing of alternative ORFs that likely accompanies all transla-
tion to some degree is sufficient to activate TCD81. The fre-
quency with which epitopes are expressed in this manner,
and the extent to which they play a role in the total re-
sponse to foreign and self antigens, remains to be deter-
mined. However, we note that the cassette system employed
may have underestimated the potential for this mechanism.
The alternative ORFs in this study are much larger than
those that naturally occur. For example, the average alter-
native ORF within NP encodes a peptide of 14 amino ac-
ids. Epitopes within such small products may be processed
and loaded onto class I molecules hundreds- to thousands
fold more efficiently than their equivalents that are part of
larger proteins (37).
Translation Termination Codons Are Efficient at Preventing
the Expression of Downstream Epitopes. A genetic region that
has great potential for supplying additional substrate for
class I–restricted epitopes is the 39 untranslated region. Part
of this region could be available for translation if the trans-
lation termination codon is bypassed to a certain extent. In
a manner similar to optimal initiation context, the se-
quence surrounding a stop codon can significantly influ-
ence translation termination (25, 39, 40), with certain se-
quences permitting a degree of leakthrough. Given the
extreme sensitivity of TCD81, even small amounts of stop
codon readthrough could make the 39 UTR of a gene
available as a source of substrate for epitope production. To
test this notion, we inserted a stop codon, with either weak
or strong termination efficiency, in RF0 of the full-length,
wild-type NP between NP147–155 and NP366–374 (Fig. 4 a).
In S. cerevisiae, the weak context stop codon has been
shown to allow 3.35% readthrough, whereas the strong
context stop codon allows only 0.36% (25). We intention-
ally placed these stop codons far into the NP ORF to elim-
Figure 3. Reversal of the cassette. (a) Two base insertions, indicated by
underline, were made to the original cassette resulting in pairing of RF0
ATG with NP50–57 and the RF-1 ATG with NP147–155. (b) Scanning be-
yond an AUG in excellent context is not sufficient to allow presentation
of NP147–155. The indicated reverse and control constructs were tested for
target cell sensitization in a standard 51Cr release assay. Specificity of the
effector populations is indicated above each data set.1056 Availability of Cryptic Epitopes for MHC Class I–restricted Presentation
inate the confounding mechanisms of scanning and reiniti-
ation that are possible in upstream regions of the message
(19, 28, 30, 41). As seen in Fig. 4 b, both stop codons were
very efficient at preventing NP366–374 presentation. As ex-
pected, NP50–57 presentation was unaffected by these ma-
nipulations because this epitope lies upstream of the inser-
tion site.
Therefore, it seems unlikely that translating ribosomes
can productively penetrate stop codons in this region of the
gene in this system. From our previous results showing
presentation of epitopes from biochemically undetectable
levels of substrate (24), we would have predicted that
3.35% readthrough of the termination codon would have
produced sufficient amounts of NP366–374 to sensitize target
cells. In our hands, NP366–374 is efficiently generated, re-
sembling NP50–57 much more than NP147–155 by several cri-
teria (Yellen-Shaw, A.J., K.A. Puorro, and L.C. Eisenlohr,
unpublished data). However, it may be that the vac expres-
sion system employed is less permissive in translation termi-
nation or that a more efficiently generated epitope would
indicate a low level of readthrough.
The unavailability of NP366–374 for presentation from
these constructs is compatible with previous data in which
frameshifts were introduced into the distal region of NP.
These frameshifts were predicted to produce termination
codons in regions of the mRNA that would not be avail-
able for reinitiation of translation (19, 41). This was con-
firmed by the loss of NP366–374 presentation (24). This ter-
mination codon efficiency is also in concurrence with the
work of Shastri and Gonzalez (13), who demonstrated that
placing a termination codon directly in front of an epitope
was highly efficient at preventing the expression of that
epitope. Given these results, we speculate that cryptic
epitope expression due to unconventional translation may
be limited to the early regions of the open reading frame.
Further investigation will be required to address this possi-
bility, including an analysis of frameshifting, in which the
actively translating ribosome shifts into a new reading
frame. This is a mechanism that would not be limited to a
particular region of the open reading frame and one that
we have begun to investigate.
With these studies, we have demonstrated the potency
of scanthrough in the 59 region of a gene. In contrast, stop
codon readthrough is apparently not available for epitope
production. These studies have further elucidated the role
of cryptic translation events in the production of substrate
for immune responses. Such epitopes could play important
roles in thymic education, TCD81-mediated autoimmunity,
cancer immunotherapy, and vaccine design.
Figure 4. Testing stop codon readthrough as a means of cryptic epitope
expression. (a) Positioning of in-frame stop codons in full-length NP. Ei-
ther a weak or a strong termination codon (25) was inserted at the BstBI
site in NP, between the NP147–155 and NP366–374 epitopes. The resulting
constructs were recombined into vac. (b) In-frame epitopes encoded after
stop codons are not presented. The constructs depicted in a and the indi-
cated control recombinants were tested for target cell sensitization in a
standard 51Cr release assay. Specificity of the effector populations is indi-
cated above each data set.
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